Rat Glucocorticoid Receptor (rGR; nr3c1)
INDIGO’s Rat Glucocorticoid Receptor (nr3c1) nuclear receptor assay utilizes proprietary non-human cells engineered to provide constitutive high-level expression of full-length, unmodified Rat Glucocorticoid Receptor (nr3c1), a ligand-dependent transcription factor, commonly referred to as GR.
DNA binding, recruitment and assembly of the co-activators and accessory factors required to form a functional transcription complex, culminating in expression of the reporter gene.
Unlike some other cell-based assay strategies, the readout from INDIGO’s reporter cells demands the same orchestration of all intracellular molecular interactions and events that can be expected to occur in vivo.
For more information on GR, visit the Nuclear Receptor Resource.
The primary application of INDIGO’s cell-based nuclear receptor assays are to quantitatively assess the bioactivity of a test compound as an agonist (activator) or antagonist (inhibition of an agonist response) of a given receptor. Service assays include a positive control reference compound and ‘vehicle’ control for every experiment. A formal study report and all data files are provided to the client upon completion of the study. To receive a quote for your proposed study, complete & submit the online “Request a Quote” form or contact an INDIGO Customer Service Representative to discuss your desired study parameters. To initiate a Service Study, download and complete all fields of the Excel worksheet “Service Work Order” then submit the electronic file to INDIGO Customer Service.